Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — SpecGx LLC

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from SpecGx LLC with status Current. The shortage was first posted on Jul 14, 2023.

Shortage details

Status
Current
Company
SpecGx LLC
Package NDC
0406-5117-01
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01)
Initial Posting
Jul 14, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.